Sonora Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Sonora Investment Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-200	Closed	-$19K	–	1139
2021 Q2	$19K	Hold	200	–	–	﹤0.01%	590
2021 Q1	$18K	Hold	200	–	–	﹤0.01%	1028
2020 Q4	$15K	Buy	+200	New	+$14.9K	﹤0.01%	1040
2017 Q2	–	Sell	-1,000	Closed	-$14.8K	–	1000
2017 Q1	$14.8K	Hold	1,000	–	–	﹤0.01%	584
2016 Q4	$16.2K	Sell	1,000 -500	-33%	-$9.07K	﹤0.01%	508
2016 Q3	$27.2K	Hold	1,500	–	–	0.01%	374
2016 Q2	$24.7K	Hold	1,500	–	–	0.01%	399
2016 Q1	$24.3K	Hold	1,500	–	–	0.01%	448
2015 Q4	$33K	Hold	1,500	–	–	0.01%	296
2015 Q3	$44K	Buy	+1,500	New	+$47.4K	0.01%	227

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sonora Investment Management's HZNP Position: Q3 2021 in Review

Sonora Investment Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2021, closing a stake of 200 shares — an estimated $19K sold.

Sonora Investment Management first reported a position in HZNP in Q3 2015 and held it in 10 quarters. The position peaked at $44K in Q3 2015. 572 funds tracked by Wall St. Rank hold HZNP as of Q3 2021.

Sonora Investment Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2021 after selling out during the quarter.
Sonora Investment Management sold 200 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2021, an estimated $19K.
Sonora Investment Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2015 and held it in 10 quarters.
Sonora Investment Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $44K in Q3 2015.
572 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.